NEWS Researchers are probing whether the blockbuster drugs that transformed obesity treatment could also quiet the brains cravings for substances such as alcohol, nicotine and opioids
About the study In the present investigator-initiated, randomized, double-blind, placebo-controlled trial studied the effects of semaglutide on albuminuria in CKD patients without diabetes across 14 centers in the Netherlands, Germany, Spain, and Canada
The primary difference is that retatrutide is a newer compound with less long-term stability data available, so following the conservative 28-day post-reconstitution window is especially important
The joint surge in prescriptions and online searches and their close correlation highlight the real-time associations between public awareness and prescription trends. Most GLP-1 Users Quit Within a Year Bernings findings were followed just days later by another study published in JAMA Network Open on January 31, by researchers at the University of Pennsylvania, who noted that GLP-1 use comes with high rates of discontinuation
Therefore, better weight loss outcomes have been documented because patients recorded significant body weight loss over one year of continuous use
